202 related articles for article (PubMed ID: 7023969)
21. Dopaminergic autoreceptors: background and implications.
Carlsson A
Adv Biochem Psychopharmacol; 1977; 16():439-41. PubMed ID: 560792
[No Abstract] [Full Text] [Related]
22. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
Marsden CD
Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
[No Abstract] [Full Text] [Related]
23. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
Conway PG; Uretsky NJ
J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019
[No Abstract] [Full Text] [Related]
24. Antidepressive effects of the stereoisomer cis-dosulepin hydrochloride.
Nakagawa T; Ukai K; Kubo S
Arzneimittelforschung; 1993 Jan; 43(1):11-5. PubMed ID: 8447840
[TBL] [Abstract][Full Text] [Related]
25. [Influence of the intracaudate administration of kainic acid on the effects of the prolonged use of haloperidol and apomorphine on rats].
Zharkovskiĭ AM; Allikmets LKh; Nurk AM
Farmakol Toksikol; 1982; 45(1):10-2. PubMed ID: 7198997
[TBL] [Abstract][Full Text] [Related]
26. Correlation between daily dosage of chlorpromazine and subsequent supersensitivity.
Klawans HL; Carvey P; Hitri A; Nausieda PA; Weiner WJ
Adv Biochem Psychopharmacol; 1980; 24():569-72. PubMed ID: 7190763
[No Abstract] [Full Text] [Related]
27. Studies on the action of (+/-)sulpiride on dopamine receptors in the rat brain in vivo.
Hasan F; Leonard BE
Neuropharmacology; 1981 Dec; 20(12B):1327-30. PubMed ID: 7198724
[No Abstract] [Full Text] [Related]
28. Biochemical aspects of experimentally induced parkinsonism.
Goldstein M; Anagnoste B; Battista AF; Nakatani S; Ogawa M
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():434-47. PubMed ID: 4403657
[No Abstract] [Full Text] [Related]
29. [The participation of the dopaminergic system of the striatum in the regulation of catalepsy in mice and rats of different genotypes].
Skrinskaia IuA; Popova NK; Nikulina EM; Kulikov AV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1997; 47(6):1032-9. PubMed ID: 9472169
[TBL] [Abstract][Full Text] [Related]
30. [Change in dopamine and serotonin receptor sensitivity following chronic chlorpromazine administration].
Zharkovskiĭ AM; Riago LK; Arro AG
Zh Vyssh Nerv Deiat Im I P Pavlova; 1980; 30(1):165-8. PubMed ID: 7189932
[TBL] [Abstract][Full Text] [Related]
31. [Biochemical bases of Parkinson disease].
Colucci d'Amato C; Puccini A; Cristillo A; Vizioli R
Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
[No Abstract] [Full Text] [Related]
32. Amphetamine behavioral toxicity: rotational behavior after chronic intrastriatal infusion.
Dougherty GG; Ellinwood EH
Biol Psychiatry; 1981 May; 16(5):479-88. PubMed ID: 7196774
[TBL] [Abstract][Full Text] [Related]
33. Brain dopamine metabolism and behavioral problems of farm animals.
Sharman DF
Adv Biochem Psychopharmacol; 1978; 19():249-54. PubMed ID: 29448
[No Abstract] [Full Text] [Related]
34. The influence of antineoplaston A5 on the central dopaminergic structures.
Juszkiewicz M; Chodkowska A; Burzynski SR; Feldo M; Majewska B; Kleinrok Z
Drugs Exp Clin Res; 1994; 20(4):161-7. PubMed ID: 7813388
[TBL] [Abstract][Full Text] [Related]
35. Aging and the regulation of striatal dopaminergic mechanisms in mice.
Randall PK; Severson JA; Finch CE
J Pharmacol Exp Ther; 1981 Dec; 219(3):695-700. PubMed ID: 7197719
[TBL] [Abstract][Full Text] [Related]
36. Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.
Fuxe K; Fredholm BB; Agnati LF; Ogren SO; Everitt BJ; Jonsson G; Gustafsson JA
Pharmacology; 1978; 16 Suppl 1():99-134. PubMed ID: 643908
[No Abstract] [Full Text] [Related]
37. Neurotoxic regimen of methamphetamine produces evidence of behavioral sensitization in the rat.
Wallace TL; Gudelsky GA; Vorhees CV
Synapse; 2001 Jan; 39(1):1-7. PubMed ID: 11071703
[TBL] [Abstract][Full Text] [Related]
38. [Drug therapy of Parkinson disease and parkinson disease-like symptoms].
Kehr W
Arzneimittelforschung; 1981; Suppl 27():26-33. PubMed ID: 7197938
[No Abstract] [Full Text] [Related]
39. Corpus striatum as the site of drug action.
Wajda IJ; Lajtha A
Vopr Biokhim Mozga; 1975; 10():107-16. PubMed ID: 1234664
[No Abstract] [Full Text] [Related]
40. Piribedil: behavioural, neurochemical and clinical profile of a dopamine agonist.
Dourish CT
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):3-27. PubMed ID: 6304814
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
